SIC
REPL icon

SJS Investment Consulting’s Replimune Group REPL Stock Holding History

SJS Investment Consulting’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42K Buy
219
+202
+1,188% +$1.24K ﹤0.01% 1694
2026
Q1 		$131 Buy
+17
New +$130 ﹤0.01% 2085

Other funds holding REPL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
PCML
Pavaki Capital Management LLC Pueblo, Colorado $287M AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

SJS Investment Consulting's REPL Position: Q2 2026 in Review

SJS Investment Consulting increased its Replimune Group (REPL) stake by 1,188% in Q2 2026, buying an estimated $1.24K and bringing the position to 219 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

SJS Investment Consulting first reported a position in REPL in Q1 2026 and has held it in 2 quarters since. 70 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • SJS Investment Consulting held 219 shares of Replimune Group worth $2.42K as of Q2 2026.
  • SJS Investment Consulting bought 202 Replimune Group shares in Q2 2026, an estimated $1.24K.
  • Replimune Group made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1694 holding.
  • SJS Investment Consulting first reported a position in Replimune Group in Q1 2026 and has held it in 2 quarters since.
  • 70 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.